High response rates with bevacizumab, docetaxel, and carboplatin in patients with HER2-negative advanced breast cancer: An experience of 22 case reports.

e11538 Background: Monoclonal antibodies, such as bevacizumab, stop tumor growth and block the ability of tumor cells to grow and spread. Others drugs find tumor cells and help kill them or carry tumor-killing substances to them. Drugs used in chemotherapy, such as docetaxel and carboplatin work in different ways to stop the growth of tumor cells, either by… CONTINUE READING